Showing 3771-3780 of 4063 results for "".
- Alcon Announces European Launch of Vivity Presbyopia-Correcting IOL With X-WAVE Technologyhttps://modernod.com/news/alcon-announces-european-launch-of-vivity-presbyopia-correcting-iol-with-x-wave-technology/2477377/Alcon announced that the AcrySof IQ Vivity IOL is now commercially available in select European markets, with additional countries to follow throughout 2020. The latest innovation in Alcon’s portfolio of presbyopia-correcting IOLs (PC-IOLs), Vivity is the first-of-its-kind, extended range
- Nicox Updates on Zerviate Progress in China and Expands the Countries of its Agreement with Ocumension Therapeuticshttps://modernod.com/news/nicox-updates-on-zerviate-progress-in-china-and-expands-the-countries-of-its-agreement-with-ocumension-therapeutics/2477370/Nicox SA announced that it has amended its March 2019 license agreement with Ocumension Therapeutics granting Ocumension exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of allergic conjunctivitis in
- AAD Annual Meeting Becomes Latest Casualty of COVID-19 Outbreakhttps://modernod.com/news/aad-annual-meeting-becomes-latest-casualty-of-covid-19-outbreak/2477371/The American Academy of Dermatology (AAD) annual meeting became the latest casualty of the COVID-19 outbreak, with the conference cancelled on Tuesday. The meeting was scheduled to be held from March 20 to 24
- Geuder Appoints Head of Innovation and Strategyhttps://modernod.com/news/geuder-appoints-head-of-innovation-and-strategy/2477355/Julius Müller-Albinus has joined Geuder as Head of Innovation Management and Strategy as of January 13, 2020. Mr. Müller-Albinus is responsible for the company-wide innovation management. Mr. Müller-Albinus will be responsible for establishing sustainable innovation processes, realizing managemen
- Alcon Introduces Systane Hydration Preservative-Free Lubricant Eye Drops for Sensitive, Dry Eyeshttps://modernod.com/news/alcon-introduces-systane-hydration-preservative-free-lubricant-eye-drops-for-sensitive-dry-eyes/2477354/Alcon has introduced Systane Hydration Preservative-Free (PF) at the SECO International 2020 meeting (#SECO2020). Systane Hydration PF lubricant eye drops is a new preservative-free option for dry eye sufferers with sensitive eyes and those in need of long-lasting relief. It is used as a protecta
- Vision Expo East Announces Speakers and Experiences for The Bridge and Innovation Stagehttps://modernod.com/news/vision-expo-east-announces-speakers-and-experiences-for-the-bridge-and-innovation-stage/2477341/Vision Expo announced the series of events and speakers planned for The Bridge and Innovation Stage at the 2020 event in New York City. In keeping with Vision Expo’s renewed focus on discovery, experience, and connection, attendees can expect a robust lineup of industry experts, creative luminari
- Retina Consultants of America Launches with Four Leading Partner Practiceshttps://modernod.com/news/retina-consultants-of-america-launches-with-four-leading-partner-practices/2477340/Retina Consultants of America (RCA), a physician management services organization recently formed by Webster Equity Partners, launched with four retina specialty practices. Practices include Retina Consultants of Houston, Retina Group of Florida, Long Island Vitreoretinal Consultants, and Retinal
- Eyevance Pharmaceuticals launches Tobradex ST in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-launches-tobradex-st-in-the-united-states/2477333/Eyevance Pharmaceuticals has announced the US launch of Tobradex ST (tobramycin/dexamethasone ophthalmic suspension) 0.3%/0.05% following the company’s acquisition of the product in late 2019. Tobradex ST is an FDA approved, fixed-dose topical antibiotic and corticosteroid combination indicated f
- FOTO-TIA: Focus on the Eye May Discriminate TIA, Stroke vs Mimicshttps://modernod.com/news/foto-tia-focus-on-the-eye-may-discriminate-tia-stroke-vs-mimics/2477330/The retinal microvasculature can help differentiate mild stroke and transient ischemic attack (TIA) from a mimic presentation, helping physicians triage patients and initiate appropriate management, new evidence suggests, according to a report
- Long-Term Data Show Value of Intravenous Chemotherapy in Retinoblastomahttps://modernod.com/news/long-term-data-show-value-of-intravenous-chemotherapy-in-retinoblastoma/2477326/Intravenous chemotherapy (IVC), with intra-arterial chemotherapy (IAC) or plaque radiotherapy as needed for globe salvage, can control retinoblastoma without the need for enucleation or external beam radiotherapy (EBRT), 20-year real-world outcomes show, according to a Reuters